IPO registrations (S-1, F-1) · Registrants
Anteris Technologies Global Corp.
- SEC CIK
- 2011514 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2024-11-22, last 2025-11-26; 2 initial registrations, 1 amendment
- Outcome
- Final prospectus filed 2024-12-13; declared effective 2024-12-12
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies 3842
- Incorporated in
- DE
- Business address
- 860 BLUE GENTIAN ROAD, SUITE 340, Eagan, MN 55121
- Ticker
- AVR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Anteris Technologies Global Corp. on the corporate pages
Offering terms
- Final price
- $6.00 per share (424B4 filed 2024-12-13, an initial public offering)
- Shares sold
- 14,800,000
- Gross proceeds
- $88,800,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AVR
- Lead underwriters
- Barclays (4,884,000 shares); Cantor Fitzgerald (2,664,000 shares); TD Securities (5,920,000 shares)
- Syndicate
- Cowen; Lake Street; Lake Street Capital Markets (1,332,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Anteris Technologies Global Corp. EXACT (CIK (EXACT))
- SEC filer: Anteris Technologies Global Corp. EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-11-22 | S-1 | S-1 (registration) | Anteris Technologies Global Corp. | 0001104659-24-122098 ↗ |
| 2024-12-09 | S-1/A | S-1/A (amendment) | Anteris Technologies Global Corp. | 0001104659-24-126560 ↗ |
| 2024-12-12 | EFFECT | EFFECT (declared effective) | Anteris Technologies Global Corp. | 9999999995-24-003765 ↗ |
| 2024-12-13 | 424B4 | 424B4 (final prospectus) | Anteris Technologies Global Corp. | 0001104659-24-128451 ↗ |
| 2025-11-26 | S-1 | S-1 (registration) | Anteris Technologies Global Corp. | 0001140361-25-043521 ↗ |
| 2025-12-11 | EFFECT | EFFECT (declared effective) | Anteris Technologies Global Corp. | 9999999995-25-003677 ↗ |
| 2026-01-08 | EFFECT | EFFECT (declared effective) | Anteris Technologies Global Corp. | 9999999995-26-000119 ↗ |
| 2026-03-13 | EFFECT | EFFECT (declared effective) | Anteris Technologies Global Corp. | 9999999995-26-000814 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-09 | S-1/A | registration statement | 14,800,000 | - | Nasdaq AVR | 5 | primary document; shares headline, cover names 4 | document ↗ | ||
| 2024-12-13 | 424B4 | final prospectus | $6.00 | 14,800,000 | $88,800,000 | Nasdaq AVR | 6 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Denaro Stephen | Director | 6 | 2024–2026 | ||
| Gu Wenyi | Director | 2 | 2024 | ||
| McDonnell Matthew | Officer | Chief Financial Officer | 5 | 2024–2026 | |
| St Denis David | Director,Officer; Officer | Chief Operating Officer | 4 | 2024–2026 | |
| Paterson Wayne | Director,Officer | Chief Executive Officer | 6 | 2024–2025 | |
| Seaberg John D | Director | 6 | 2024–2025 | ||
| L1 Capital Pty Ltd | TenPercentOwner | 11 | 2025–2026 | ||
| Moss Gregory S. | Director | 3 | 2025–2026 | ||
| Roberts David B | Director | 3 | 2025–2026 | ||
| Medtronic plc | TenPercentOwner | 1 | 2026 | ||
| Knight Susan Elizabeth | Director | 2 | 2026 | ||
| Moen Brent | Officer | Chief Financial Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-11-07 | Anteris Technologies Global Corp. | Biotechnology | $11,499,987 | $11,499,987 | 9 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Anteris Technologies Global Corp. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Anteris Technologies Global Corp. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Orthopedic, Prosthetic & Surgical Appliances & Supplies, MN first:
- AMERICAN MEDICAL SYSTEMS HOLDINGS INC MN
- Restore Medical, Inc. MN
- Envoy Medical, Inc. MN
- BioHorizons, Inc. AL
- LAKELAND INDUSTRIES INC AL
- ALIGN TECHNOLOGY INC AZ
- CARDIMA INC CA
- INTUITIVE SURGICAL INC CA
- DJ ORTHOPEDICS CAPITAL CORP CA
- DJO, LLC CA
In other datasets, the same topic (Technology) in MN:
- Form D issuer: 313 Software, LLC (Form D private offerings)
- Lobbying client: ACA INTERNATIONAL (Federal lobbying (LDA))
Interests: Orthopedic, Prosthetic & Surgical Appliances & Supplies · Technology